No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
61 |
4. Check minimum number of eventsNone |
61 |
5. Include endpointsNone |
61 |
6. Filter based on genotype QC (FinnGen only) |
54 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
- Parent code in ICD-10
- C45-C49
- Name in latin
- Sarcoma Kaposi
Similar endpoints
↥List of similar endpoints to
Kaposi sarcoma, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm, wide definition for exclusion
- Neoplasms
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: unknown.
No upset table: unknown.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 54 | 14 | 40 |
| Unadjusted period prevalence (%) | 0.01 | 0.00 | 0.02 |
| Median age at first event (years) | 73.11 | 68.35 | 74.77 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 61
- Matched controls
- 610
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N02BE01, ,
ATC
paracetamol; systemic, rectal
+∞
62.7
49
*
J01DB01, ,
ATC
cefalexin; oral
+∞
61.0
48
*
A98, ,
ICD-O-3
+∞
57.8
46
*
J01AA02, ,
ATC
doxycycline; systemic
+∞
56.2
45
*
J01CA04, ,
ATC
amoxicillin; systemic
+∞
54.6
44
*
M01AE01, ,
ATC
ibuprofen; systemic, rectal
+∞
47.1
39
*
C460, ,
ICD-10 Finland
Kaposi sarcoma of skin
+∞
45.7
38
*
J01CE02, ,
ATC
phenoxymethylpenicillin; oral
+∞
44.2
37
*
A02BC02, ,
ATC
pantoprazole; systemic
+∞
41.4
35
*
WX110, ,
ICD-O-3
+∞
41.4
35
*
SAA01, ,
ICD-O-3
+∞
37.4
32
*
J01DA01, ,
ATC
[U] cefalexin
+∞
37.4
32
*
M01AB05, ,
ATC
diclofenac; systemic, rectal
+∞
36.0
31
*
C03CA01, ,
ATC
furosemide; systemic
+∞
36.0
31
*
I10, ,
ICD-10 Finland
Essential (primary) hypertension
+∞
34.7
30
*
C07AB07, ,
ATC
bisoprolol; oral
+∞
32.1
28
*
ZXE10, ,
ICD-O-3
+∞
30.9
27
*
S18, ,
ICD-O-3
+∞
30.9
27
*
S01XA20, ,
ATC
artificial tears and other indifferent preparations; ophthalmic
+∞
30.9
27
*
J01CR02, ,
ATC
amoxicillin and beta-lactamase inhibitor; systemic
+∞
30.9
27
*
R03AC02, ,
ATC
salbutamol; inhalant
+∞
29.6
26
*
J01MA02, ,
ATC
ciprofloxacin; systemic
+∞
29.6
26
*
SAA02, ,
ICD-O-3
+∞
28.3
25
*
EB1AA, ,
ICD-O-3
+∞
28.3
25
*
J01FA10, ,
ATC
azithromycin; systemic
+∞
28.3
25
*
H02AB06, ,
ATC
prednisolone; systemic
+∞
27.1
24
*
P01AB01, ,
ATC
metronidazole; oral, rectal
+∞
25.9
23
*
I10, ,
ICD-O-3
+∞
25.9
23
*
J189, ,
ICD-10 Finland
Pneumonia, unspecified
+∞
25.9
23
*
M01AH05, ,
ATC
etoricoxib; oral
+∞
25.9
23
*
ZXD10, ,
ICD-O-3
+∞
25.9
23
*
WYA05, ,
ICD-O-3
+∞
24.6
22
*
GD1AA, ,
ICD-O-3
+∞
24.6
22
*
D07AC01, ,
ATC
betamethasone; topical
+∞
24.6
22
*
R05FB02, ,
ATC
cough suppressants and expectorants; systemic
+∞
24.6
22
*
SFA20, ,
ICD-O-3
+∞
24.6
22
*
N02AX02, ,
ATC
tramadol; systemic, rectal
+∞
24.6
22
*
CJE20, ,
ICD-O-3
+∞
23.4
21
*
E0000UV, ,
ATC
+∞
23.4
21
*
S01CA01, ,
ATC
dexamethasone and antiinfectives; ophthalmic
+∞
23.4
21
*
UJD10, ,
ICD-O-3
+∞
23.4
21
*
WZC00, ,
ICD-O-3
+∞
23.4
21
*
C447, 9140, 3
O3
+∞
23.4
21
*
M01AE02, ,
ATC
naproxen; oral, rectal
+∞
23.4
21
*
J01MA12, ,
ATC
levofloxacin; systemic
+∞
23.4
21
*
A12AX, ,
ATC
Calcium, combinations with vitamin D and/or other drugs
+∞
22.2
20
*
N05CF01, ,
ATC
zopiclone; oral
+∞
22.2
20
*
G04CA02, ,
ATC
tamsulosin; oral
+∞
22.2
20
*
N02AA59, ,
ATC
codeine, combinations excl. psycholeptics; systemic
+∞
21.0
19
*
B01AB05, ,
ATC
enoxaparin; parenteral
+∞
21.0
19
*
C09AA05, ,
ATC
ramipril; oral
+∞
21.0
19
*
ZXD05, ,
ICD-O-3
+∞
21.0
19
*
M01AE03, ,
ATC
ketoprofen; systemic, rectal
+∞
21.0
19
*
M03BX02, ,
ATC
tizanidine; oral
+∞
21.0
19
*
J01FA06, ,
ATC
roxithromycin; oral
+∞
21.0
19
*
SPAT1263, ,
ICD-O-3
+∞
21.0
19
*
205, ,
Kela drug reimbursment
Chronic hypertension
+∞
19.9
18
*
N02AJ06, ,
ATC
codeine and paracetamol; systemic
+∞
19.9
18
*
I48, ,
ICD-10 Finland
Atrial fibrillation and flutter
+∞
19.9
18
*
C08CA01, ,
ATC
amlodipine; oral
+∞
19.9
18
*
KMAK, ,
ICD-O-3
+∞
19.9
18
*
A02BC01, ,
ATC
omeprazole; systemic
+∞
19.9
18
*
SFA10, ,
ICD-O-3
+∞
19.9
18
*
N40, ,
ICD-10 Finland
Hyperplasia of prostate
+∞
19.9
18
*
H251, ,
ICD-10 Finland
Senile nuclear cataract
+∞
19.9
18
*
W01, ,
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
+∞
19.9
18
*
ZXE00, ,
ICD-O-3
+∞
19.9
18
*
ZXA00, ,
ICD-O-3
+∞
18.7
17
*
Z3231, ,
ICD-O-3
+∞
18.7
17
*
J01EA01, ,
ATC
trimethoprim; systemic
+∞
18.7
17
*
R06AE07, ,
ATC
cetirizine; oral
+∞
18.7
17
*
A02BC05, ,
ATC
esomeprazole; systemic
+∞
18.7
17
*
Z2221, ,
ICD-O-3
+∞
18.7
17
*
SFA30, ,
ICD-O-3
+∞
18.7
17
*
TQX10, ,
ICD-O-3
+∞
18.7
17
*
C10AA01, ,
ATC
simvastatin; oral
+∞
18.7
17
*
K021, ,
ICD-O-3
+∞
18.7
17
*
R4110, ,
ICD-O-3
+∞
17.5
16
*
EBA00, ,
ICD-O-3
+∞
17.5
16
*
B01AA03, ,
ATC
warfarin; systemic
+∞
17.5
16
*
J01FF01, ,
ATC
clindamycin; systemic
+∞
17.5
16
*
WX408, ,
ICD-O-3
+∞
17.5
16
*
-1, ,
ICD-O-3
+∞
17.5
16
*
R05, ,
ICD-O-3
+∞
17.5
16
*
SPAT1256, ,
ICD-O-3
+∞
17.5
16
*
J02AC01, ,
ATC
fluconazole; systemic
+∞
17.5
16
*
SPAT1325, ,
ICD-O-3
+∞
17.5
16
*
SAA03, ,
ICD-O-3
+∞
16.4
15
*
WW200, ,
ICD-O-3
+∞
16.4
15
*
J01EE02, ,
ATC
sulfadiazine and trimethoprim; systemic
+∞
16.4
15
*
D01AC20, ,
ATC
imidazoles/triazoles in combination with corticosteroids; topical
+∞
16.4
15
*
M796, ,
ICD-O-3
+∞
16.4
15
*
C10AA05, ,
ATC
atorvastatin; oral
+∞
16.4
15
*
C01DA02, ,
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
+∞
16.4
15
*
WX320, ,
ICD-O-3
+∞
16.4
15
*
Z012, ,
ICD-O-3
+∞
16.4
15
*
UKC02, ,
ICD-O-3
+∞
16.4
15
*
R05FA02, ,
ATC
opium derivatives and expectorants; systemic
+∞
16.4
15
*
SPAT1301, ,
ICD-O-3
+∞
16.4
15
*
Z871, ,
ICD-O-3
+∞
15.2
14
*
A28, ,
ICD-O-3
+∞
15.2
14
*
SPAT1153, ,
ICD-O-3
+∞
15.2
14
*
E119, ,
ICD-10 Finland
Type 2 diabetes mellitus, without complications
+∞
15.2
14
*
XKD00, ,
ICD-O-3
+∞
15.2
14
*
N05CD07, ,
ATC
temazepam; oral
+∞
15.2
14
*
M02AA07, ,
ATC
piroxicam; topical
+∞
15.2
14
*
D07AC13, ,
ATC
mometasone; topical
+∞
15.2
14
*
C07AB02, ,
ATC
metoprolol; systemic
+∞
15.2
14
*
A03FA01, ,
ATC
metoclopramide; systemic, rectal
+∞
15.2
14
*
R509, ,
ICD-10 Finland
Fever, unspecified
+∞
15.2
14
*
L17, ,
ICD-O-3
+∞
15.2
14
*
J01CA08, ,
ATC
pivmecillinam; oral
+∞
15.2
14
*
R01AD08, ,
ATC
fluticasone; nasal
+∞
15.2
14
*
Z024, ,
ICD-O-3
+∞
15.2
14
*
ZXA05, ,
ICD-O-3
+∞
14.1
13
*
D01BA02, ,
ATC
terbinafine; oral
+∞
14.1
13
*
N06AX11, ,
ATC
mirtazapine; oral
+∞
14.1
13
*
L309, ,
ICD-O-3
+∞
14.1
13
*
J05AB11, ,
ATC
valaciclovir; oral
+∞
14.1
13
*
SPAT1148, ,
ICD-O-3
+∞
14.1
13
*
J069, ,
ICD-O-3
+∞
14.1
13
*
S29, ,
ICD-O-3
+∞
14.1
13
*
N02AA05, ,
ATC
oxycodone; systemic
+∞
14.1
13
*
103, ,
Kela drug reimbursment
Diabetes, insulin-treated
+∞
14.1
13
*
R03BA05, ,
ATC
fluticasone; inhalant
+∞
14.1
13
*
SFA40, ,
ICD-O-3
+∞
14.1
13
*
UJF32, ,
ICD-O-3
+∞
14.1
13
*
A10BA02, ,
ATC
metformin; oral
+∞
14.1
13
*
A06AC01, ,
ATC
ispaghula (psylla seeds); oral
+∞
14.1
13
*
WX290, ,
ICD-O-3
+∞
14.1
13
*
SPAT1253, ,
ICD-O-3
+∞
14.1
13
*
N05BA04, ,
ATC
oxazepam; oral
+∞
14.1
13
*
SPAT1249, ,
ICD-O-3
+∞
14.1
13
*
A46, ,
ICD-10 Finland
Erysipelas
+∞
14.1
13
*
SDA03, ,
ICD-O-3
+∞
13.0
12
*
SPAT1310, ,
ICD-O-3
+∞
13.0
12
*
X59, ,
ICD-10 Finland
Exposure to unspecified factor
+∞
13.0
12
*
C469, ,
ICD-10 Finland
Kaposi sarcoma, unspecified
+∞
13.0
12
*
WX402, ,
ICD-O-3
+∞
13.0
12
*
C01DA08, ,
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
+∞
13.0
12
*
C09CA06, ,
ATC
candesartan; oral
+∞
13.0
12
*
WZB00, ,
ICD-O-3
+∞
13.0
12
*
SPAT1312, ,
ICD-O-3
+∞
13.0
12
*
QAE10, ,
ICD-O-3
+∞
13.0
12
*
Z760, ,
ICD-O-3
+∞
11.8
11
*
K85, ,
ICD-O-3
+∞
11.8
11
*
D07AB02, ,
ATC
hydrocortisone butyrate; topical
+∞
11.8
11
*
SPAT1262, ,
ICD-O-3
+∞
11.8
11
*
N03AX16, ,
ATC
[U] pregabalin
+∞
11.8
11
*
R238, ,
ICD-O-3
+∞
11.8
11
*
R03BA02, ,
ATC
budesonide; inhalant
+∞
11.8
11
*
EB1HA, ,
ICD-O-3
+∞
11.8
11
*
I251, ,
ICD-10 Finland
Atherosclerotic heart disease
+∞
11.8
11
*
M545, ,
ICD-O-3
+∞
11.8
11
*
WX002, ,
ICD-O-3
+∞
11.8
11
*
Z718, ,
ICD-O-3
+∞
11.8
11
*
D485, ,
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
+∞
11.8
11
*
A02BC03, ,
ATC
lansoprazole; oral
+∞
10.7
10
*
SPAT1149, ,
ICD-O-3
+∞
10.7
10
*
SFC01, ,
ICD-O-3
+∞
10.7
10
*
S21, ,
ICD-O-3
+∞
10.7
10
*
P20, ,
ICD-O-3
+∞
10.7
10
*
FM1EE, ,
ICD-O-3
+∞
10.7
10
*
Z3229, ,
ICD-O-3
+∞
10.7
10
*
WF004, ,
ICD-O-3
+∞
10.7
10
*
QDE10, ,
ICD-O-3
+∞
10.7
10
*
PH2AE, ,
ICD-O-3
+∞
10.7
10
*
C09CA01, ,
ATC
losartan; oral
+∞
10.7
10
*
D19, ,
ICD-O-3
+∞
10.7
10
*
SDA01, ,
ICD-O-3
+∞
10.7
10
*
TQW40, ,
ICD-O-3
+∞
10.7
10
*
FM1AE, ,
ICD-O-3
+∞
10.7
10
*
SPAT1230, ,
ICD-O-3
+∞
10.7
10
*
TPH04, ,
ICD-O-3
+∞
10.7
10
*
C460, ,
ICD-O-3
+∞
10.7
10
*
M04AA01, ,
ATC
allopurinol; systemic
+∞
10.7
10
*
R05DA20, ,
ATC
opium alkaloids and derivatives - combinations
+∞
10.7
10
*
SPAT1223, ,
ICD-O-3
+∞
10.7
10
*
D07AB08, ,
ATC
desonide; topical
+∞
10.7
10
*
J05AB01, ,
ATC
aciclovir; systemic
+∞
10.7
10
*
203, ,
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
+∞
10.7
10
*
Z3226, ,
ICD-O-3
+∞
10.7
10
*
M255, ,
ICD-O-3
+∞
10.7
10
*
J209, ,
ICD-O-3
+∞
10.7
10
*
J01FA09, ,
ATC
clarithromycin; systemic
+∞
10.7
10
*
Z712, ,
ICD-O-3
+∞
10.7
10
*
215, ,
Kela drug reimbursment
Diabetes, non-insulin-treated
+∞
9.6
9
*
EB1SA, ,
ICD-O-3
+∞
9.6
9
*
N03AX12, ,
ATC
[U] gabapentin; oral
+∞
9.6
9
*
JN3AE, ,
ICD-O-3
+∞
9.6
9
*
SPAT1229, ,
ICD-O-3
+∞
9.6
9
*
N40, ,
ICD-O-3
+∞
9.6
9
*
ZXA10, ,
ICD-O-3
+∞
9.6
9
*
JN4BD, ,
ICD-O-3
+∞
9.6
9
*
SPAT1033, ,
ICD-O-3
+∞
9.6
9
*
R01AD09, ,
ATC
mometasone; nasal
+∞
9.6
9
*
L15, ,
ICD-O-3
+∞
9.6
9
*
R01BA52, ,
ATC
pseudoephedrine, combinations; oral
+∞
9.6
9
*
H81, ,
ICD-O-3
+∞
9.6
9
*
L03, ,
ICD-O-3
+∞
9.6
9
*
XX3DW, ,
ICD-O-3
+∞
9.6
9
*
SDE02, ,
ICD-O-3
+∞
9.6
9
*
SPAT1250, ,
ICD-O-3
+∞
9.6
9
*
WX404, ,
ICD-O-3
+∞
9.6
9
*
R03AK07, ,
ATC
formoterol and budesonide; inhalant
+∞
9.6
9
*
I509, ,
ICD-10 Finland
Heart failure, unspecified
+∞
9.6
9
*
206, ,
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
+∞
9.6
9
*
C01DA14, ,
ATC
isosorbide mononitrate; oral
+∞
9.6
9
*
D07AA02, ,
ATC
hydrocortisone; topical
+∞
9.6
9
*
I48, ,
ICD-O-3
+∞
9.6
9
*
K573, ,
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
+∞
9.6
9
*
GD1PA, ,
ICD-O-3
+∞
9.6
9
*
SPAT1216, ,
ICD-O-3
+∞
9.6
9
*
G04CB01, ,
ATC
finasteride; oral
+∞
9.6
9
*
WZC30, ,
ICD-O-3
+∞
9.6
9
*
N06AB04, ,
ATC
citalopram; systemic
+∞
9.6
9
*
A46, ,
ICD-O-3
+∞
9.6
9
*
D07XC01, ,
ATC
betamethasone; topical
+∞
9.6
9
*
A499, ,
ICD-10 Finland
Bacterial infection, unspecified
+∞
9.6
9
*
A09, ,
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
+∞
9.6
9
*
J01DA09, ,
ATC
[U] cefadroxil
+∞
9.6
9
*
T90, ,
ICD-O-3
+∞
8.5
8
*
A97, ,
ICD-O-3
+∞
8.5
8
*
K045, ,
ICD-O-3
+∞
8.5
8
*
Z961, ,
ICD-10 Finland
Presence of intraocular lens
+∞
8.5
8
*
B02AA02, ,
ATC
tranexamic acid; systemic
+∞
8.5
8
*
H02AB04, ,
ATC
methylprednisolone; systemic
+∞
8.5
8
*
QDB10, ,
ICD-O-3
+∞
8.5
8
*
M01AH01, ,
ATC
celecoxib; oral
+∞
8.5
8
*
Z010, ,
ICD-10 Finland
Examination of eyes and vision
+∞
8.5
8
*
ZX012, ,
ICD-O-3
+∞
8.5
8
*
M03BC51, ,
ATC
orphenadrine, combinations; systemic
+∞
8.5
8
*
N02AE01, ,
ATC
buprenorphine; parenteral, sublingual, transdermal
+∞
8.5
8
*
M05BA04, ,
ATC
alendronic acid; oral
+∞
8.5
8
*
FN1AC, ,
ICD-O-3
+∞
8.5
8
*
207, ,
Kela drug reimbursment
Chronic arrhythmias
+∞
8.5
8
*
R53, ,
ICD-10 Finland
Malaise and fatigue
+∞
8.5
8
*
R060, ,
ICD-10 Finland
Dyspnoea
+∞
8.5
8
*
A06AD11, ,
ATC
lactulose; oral
+∞
8.5
8
*
XF400, ,
ICD-O-3
+∞
8.5
8
*
WX700, ,
ICD-O-3
+∞
8.5
8
*
SDA02, ,
ICD-O-3
+∞
8.5
8
*
G03CA03, ,
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
+∞
8.5
8
*
R05DA01, ,
ATC
ethylmorphine; oral
+∞
8.5
8
*
E000001, ,
ATC
+∞
8.5
8
*
J01AA07, ,
ATC
tetracycline; systemic
+∞
8.5
8
*
QBE10, ,
ICD-O-3
+∞
8.5
8
*
114, ,
Kela drug reimbursment
Glaucoma
+∞
8.5
8
*
AA1AD, ,
ICD-O-3
+∞
8.5
8
*
N10, ,
ICD-10 Finland
Acute tubulo-interstitial nephritis
+∞
8.5
8
*
H02AB07, ,
ATC
prednisone; oral
+∞
8.5
8
*
C10AA07, ,
ATC
rosuvastatin; oral
+∞
8.5
8
*
G301, ,
ICD-10 Finland
Alzheimer disease with late onset
+∞
8.5
8
*
C01AA05, ,
ATC
digoxin; systemic
+∞
8.5
8
*
A29, ,
ICD-O-3
+∞
8.5
8
*
117, ,
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
+∞
8.5
8
*
SPAT1222, ,
ICD-O-3
+∞
8.5
8
*
SPAT1254, ,
ICD-O-3
+∞
8.5
8
*
H258, ,
ICD-10 Finland
Other senile cataract
+∞
8.5
8
*
GD1QA, ,
ICD-O-3
+∞
8.5
8
*
ZZA00, ,
ICD-O-3
+∞
8.5
8
*
R238, ,
ICD-10 Finland
Other and unspecified skin changes
+∞
8.5
8
*
H13, ,
ICD-O-3
+∞
8.5
8
*
Z011, ,
ICD-10 Finland
Examination of ears and hearing
+∞
8.5
8
*
M796, ,
ICD-10 Finland
Pain in limb
+∞
7.4
7
*
C09AA02, ,
ATC
enalapril; systemic
+∞
7.4
7
*
R5110, ,
ICD-O-3
+∞
7.4
7
*
M171, ,
ICD-10 Finland
Other primary gonarthrosis
+∞
7.4
7
*
UGC12, ,
ICD-O-3
+∞
7.4
7
*
B01AC04, ,
ATC
clopidogrel; oral
+∞
7.4
7
*
290, ,
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
+∞
7.4
7
*
A02BA02, ,
ATC
ranitidine; systemic
+∞
7.4
7
*
SDE03, ,
ICD-O-3
+∞
7.4
7
*
R03DC03, ,
ATC
montelukast; oral
+∞
7.4
7
*
351, ,
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
+∞
7.4
7
*
J02AC02, ,
ATC
itraconazole; systemic
+∞
7.4
7
*
ZX120, ,
ICD-O-3
+∞
7.4
7
*
WYA30, ,
ICD-O-3
+∞
7.4
7
*
B231, ,
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
+∞
7.4
7
*
C619, 8140, 3
O3
+∞
7.4
7
*
R074, ,
ICD-10 Finland
Chest pain, unspecified
+∞
7.4
7
*
F03, ,
ICD-10 Finland
Unspecified dementia
+∞
7.4
7
*
D07AD01, ,
ATC
clobetasol; topical
+∞
7.4
7
*
L08, ,
ICD-O-3
+∞
7.4
7
*
E7801, ,
ICD-10 Finland
Pure hypercholesterolaemia
+∞
7.4
7
*
M01AC06, ,
ATC
meloxicam; systemic, rectal
+∞
7.4
7
*
S04, ,
ICD-O-3
+∞
7.4
7
*
S01ED51, ,
ATC
timolol, combinations; ophthalmic
+∞
7.4
7
*
M01AX17, ,
ATC
nimesulide; oral
+∞
7.4
7
*
M255, ,
ICD-10 Finland
Pain in joint
+∞
7.4
7
*
N05BA01, ,
ATC
diazepam; systemic, rectal
+∞
7.4
7
*
D07CC01, ,
ATC
betamethasone and antibiotics; topical
+∞
7.4
7
*
R104, ,
ICD-10 Finland
Other and unspecified abdominal pain
+∞
7.4
7
*
M03BC01, ,
ATC
orphenadrine (citrate); systemic
+∞
7.4
7
*
JAB30, ,
ICD-O-3
+∞
7.4
7
*
R31, ,
ICD-10 Finland
Unspecified haematuria
+∞
7.4
7
*
Z718, ,
ICD-10 Finland
Other specified counselling
+∞
7.4
7
*
N06DA02, ,
ATC
donepezil; oral
+∞
7.4
7
*
VALMI, ,
ICD-O-3
+∞
7.4
7
*
G04CA01, ,
ATC
alfuzosin; oral
+∞
7.4
7
*
UJF30, ,
ICD-O-3
+∞
7.4
7
*
N05CF02, ,
ATC
zolpidem; oral
+∞
7.4
7
*
I842, ,
ICD-10 Finland
Internal hemorrhoids without complication
+∞
7.4
7
*
R74, ,
ICD-O-3
+∞
7.4
7
*
J01MA01, ,
ATC
ofloxacin; systemic
+∞
7.4
7
*
C61, ,
ICD-10 Finland
Malignant neoplasm of prostate
+∞
7.4
7
*
R2130, ,
ICD-O-3
+∞
7.4
7
*
H29, ,
ICD-O-3
+∞
7.4
7
*
N06DX01, ,
ATC
memantine; oral
+∞
7.4
7
*
R5180, ,
ICD-10 Finland
Headache
+∞
7.4
7
*
SPAT1255, ,
ICD-O-3
+∞
7.4
7
*
K0365, ,
ICD-O-3
+∞
7.4
7
*
R600, ,
ICD-O-3
+∞
7.4
7
*
XJH00, ,
ICD-O-3
+∞
7.4
7
*
SPAT1097, ,
ICD-O-3
+∞
7.4
7
*
J01MA14, ,
ATC
moxifloxacin; systemic
+∞
6.3
6
*
H03AA01, ,
ATC
levothyroxine sodium; systemic
+∞
6.3
6
*
GD1BD, ,
ICD-O-3
+∞
6.3
6
*
R91, ,
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
+∞
6.3
6
*
N189, ,
ICD-10 Finland
Chronic kidney disease, unspecified
+∞
6.3
6
*
M01AB01, ,
ATC
indometacin; systemic, rectal
+∞
6.3
6
*
A04AA02, ,
ATC
granisetron; systemic, transdermal
+∞
6.3
6
*
M01AH02, ,
ATC
rofecoxib; oral
+∞
6.3
6
*
L309, ,
ICD-10 Finland
Dermatitis, unspecified
+∞
6.3
6
*
Z018, ,
ICD-10 Finland
Other specified special examinations
+∞
6.3
6
*
SPAT1043, ,
ICD-O-3
+∞
6.3
6
*
ZXD20, ,
ICD-O-3
+∞
6.3
6
*
GD1AD, ,
ICD-O-3
+∞
6.3
6
*
NH1AA, ,
ICD-O-3
+∞
6.3
6
*
R01AD01, ,
ATC
beclometasone; nasal
+∞
6.3
6
*
H903, ,
ICD-10 Finland
Sensorineural hearing loss, bilateral
+∞
6.3
6
*
Z515, ,
ICD-10 Finland
Palliative care
+∞
6.3
6
*
J069, ,
ICD-10 Finland
Acute upper respiratory infection, unspecified
+∞
6.3
6
*
SPAT1053, ,
ICD-O-3
+∞
6.3
6
*
TFP20, ,
ICD-O-3
+∞
6.3
6
*
JHB30, ,
ICD-O-3
+∞
6.3
6
*
WF049, ,
ICD-O-3
+∞
6.3
6
*
R03AC03, ,
ATC
terbutaline; inhalant
+∞
6.3
6
*
WD105, ,
ICD-O-3
+∞
6.3
6
*
D07BA04, ,
ATC
hydrocortisone and antiseptics; topical
+∞
6.3
6
*
S01GX01, ,
ATC
cromoglicic acid; ophthalmic
+∞
6.3
6
*
K0364, ,
ICD-O-3
+∞
6.3
6
*
D649, ,
ICD-10 Finland
Anaemia, unspecified
+∞
6.3
6
*
XW000, ,
ICD-O-3
+∞
6.3
6
*
A03, ,
ICD-O-3
+∞
6.3
6
*
M160, ,
ICD-10 Finland
Primary coxarthrosis, bilateral
+∞
6.3
6
*
M751, ,
ICD-10 Finland
Rotator cuff syndrome
+∞
6.3
6
*
K409, ,
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
+∞
6.3
6
*
A10BH01, ,
ATC
sitagliptin; oral
+∞
6.3
6
*
ZXE20, ,
ICD-O-3
+∞
6.3
6
*
D82, ,
ICD-O-3
+∞
6.3
6
*
SPAT1156, ,
ICD-O-3
+∞
6.3
6
*
WF002, ,
ICD-O-3
+∞
6.3
6
*
C463, ,
ICD-10 Finland
Kaposi sarcoma of lymph nodes
+∞
6.3
6
*
J159, ,
ICD-10 Finland
Bacterial pneumonia, unspecified
+∞
6.3
6
*
R01AD12, ,
ATC
fluticasone furoate; nasal
+∞
6.3
6
*
N05AH04, ,
ATC
quetiapine; oral
+∞
6.3
6
*
L14, ,
ICD-O-3
+∞
6.3
6
*
C449, 9140, 3
O3
+∞
6.3
6
*
LC2BE, ,
ICD-O-3
+∞
6.3
6
*
A11, ,
ICD-O-3
+∞
6.3
6
*
C467, ,
ICD-10 Finland
Kaposi sarcoma of other sites
+∞
6.3
6
*
N05BA12, ,
ATC
alprazolam; oral
+∞
6.3
6
*
Z039, ,
ICD-O-3
+∞
6.3
6
*
R33, ,
ICD-10 Finland
Retention of urine
+∞
6.3
6
*
KC1EE, ,
ICD-O-3
+∞
6.3
6
*
C08CA13, ,
ATC
lercanidipine; oral
+∞
6.3
6
*
R02, ,
ICD-O-3
+∞
6.3
6
*
SPAT1217, ,
ICD-O-3
+∞
6.3
6
*
J45, ,
ICD-O-3
+∞
6.3
6
*
KED22, ,
ICD-O-3
+∞
6.3
6
*
G459, ,
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
+∞
6.3
6
*
GD1UA, ,
ICD-O-3
+∞
6.3
6
*
R060, ,
ICD-O-3
+∞
6.3
6
*
YN1BD, ,
ICD-O-3
+∞
6.3
6
*
R03BB04, ,
ATC
tiotropium bromide; inhalant
+∞
6.3
6
*
M751, ,
ICD-O-3
+∞
6.3
6
*
A10AE04, ,
ATC
insulin glargine; parenteral
+∞
6.3
6
*
G473, ,
ICD-10 Finland
Sleep apnoea
+∞
6.3
6
*
JN3AD, ,
ICD-O-3
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
34
187
2.85
3.89
12.4
3.1
9.91
13.39
umol/l
1.76
34
176
8
17
5.24
3.03
3.7
1.6
—
—
—
0
0
24
130
2.40
2.62
3.8
3.0
—
—
—
0
0
12
47
2.93
2.44
2.8
2.3
2.27
2.21
g/l
0.10
12
41
25
145
2.23
2.28
6.0
2.1
—
—
—
0
0
13
56
2.68
2.23
2.8
2.1
11.52
12.30
umol/l
0.12
13
51
6
14
4.63
2.21
5.7
1.6
0.51
0.62
ug/l
—
6
9
6
14
4.63
2.21
1.7
1.4
—
—
—
0
0
8
25
3.52
2.18
2.5
1.3
—
—
—
0
0
11
44
2.83
2.15
4.3
3.0
—
—
—
0
0
6
15
4.31
2.09
4.3
1.4
—
—
—
0
0
28
176
2.09
2.05
7.2
4.7
0.00
0.00
estimate
—
5
32
18
95
2.27
2.02
4.4
2.5
361.28
5324.55
umol/l
0.50
18
83
13
61
2.44
1.88
2.3
2.5
1.49
0.74
e6/l
—
7
32
28
181
2.01
1.86
5.3
3.5
0.00
0.00
estimate
—
6
31
7
23
3.30
1.86
5.6
3.7
0.06
0.21
e6/l
—
7
23
14
69
2.34
1.82
2.9
1.8
—
—
—
0
0
27
174
1.99
1.80
5.2
3.5
0.00
0.00
estimate
—
7
37
13
64
2.31
1.69
3.1
2.7
1.36
1.61
e6/l
—
7
35
29
200
1.86
1.53
33.7
18.9
1.70
1.43
inr
—
7
67
6
23
2.78
1.40
3.2
4.0
71.50
81.67
ng/l
—
6
18
16
99
1.84
1.14
1.7
1.8
1.40
1.25
mmol/l
0.32
16
83
7
32
2.34
1.12
1.4
1.4
33.57
27.48
u/l
—
7
27
23
160
1.70
1.11
1.7
2.0
86.02
84.39
pmol/l
0.07
17
75
11
64
1.88
0.93
2.1
1.5
—
—
—
0
0
15
97
1.72
0.92
4.3
3.7
0.00
0.00
estimate
—
5
29
43
364
1.61
0.88
25.6
13.0
76.35
72.89
ml/min/173m2
0.37
34
289
6
32
1.97
0.84
1.8
6.7
108.00
124.75
g/l
—
6
32
6
33
1.91
0.81
5.3
2.9
1.22
2.21
mmol/l
—
6
25
5
25
2.09
0.74
1.0
1.5
—
—
—
0
0
7
41
1.80
0.73
1.4
1.5
—
—
—
0
0
7
43
1.71
0.69
1.1
1.5
—
—
—
0
0
8
51
1.65
0.63
6.8
1.8
0.74
0.84
mmol/l
—
8
46
19
144
1.46
0.60
5.4
3.5
—
—
—
0
0
46
413
1.46
0.56
34.4
15.7
83.33
87.52
umol/l
0.52
46
413
44
395
1.41
0.51
32.4
13.3
23.89
25.08
mg/l
0.11
38
306
15
115
1.40
0.44
1.9
1.7
52.07
95.66
u/l
0.54
15
108
5
36
1.42
0.39
2.8
1.4
1.38
1.73
%
—
5
30
9
70
1.33
0.39
1.1
1.2
—
0.97
—
0
19
6
46
1.34
0.34
1.8
6.1
4.75
5.15
kpa
—
6
41
23
196
1.28
0.34
2.1
2.4
—
—
—
0
0
47
439
1.31
0.31
43.4
18.7
131.57
137.33
g/l
1.25
47
423
44
408
1.28
0.31
31.4
16.7
138.93
139.83
mmol/l
1.30
44
390
44
411
1.25
0.27
31.5
16.6
4.02
4.03
mmol/l
0.05
44
393
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
6
47
1.31
0.21
3.8
4.9
101.67
104.89
mmol/l
—
6
47
19
169
1.18
0.17
5.9
3.5
18.00
25.09
%
—
6
69
14
122
1.19
0.15
3.1
2.7
0.69
0.77
ug/l
—
9
76
40
385
1.11
0.09
13.7
4.9
6.13
6.16
mmol/l
0.07
35
339
28
268
1.08
0.06
4.1
3.2
15.71
14.86
pmol/l
0.72
23
230
15
139
1.10
0.06
2.3
2.2
150.53
215.93
u/l
0.58
15
129
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_KAPOSI_SARCOMA_WIDE – Kaposi sarcoma, including Hilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).